Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 23 Apr 2023
According to the study, prolonged exposure to nitrogen dioxide, particulate matter PM2.5, and nitrogen oxide may raise the risk of dementia.
Read Full NewsThe AAN's new guideline enhances diagnosis and management of functional seizures, emphasizing psychological interventions and addressing care gaps for better patient outcomes.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 30, 2026.
Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.
Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.
FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis
6 Nephrology Headlines You Missed In January 2026
OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis
1.
Advanced breast cancer patients living longer thanks to improvements in treatment and care
2.
Hemihedral resection not necessary for neuroendocrine surgery after appendicitis
3.
Accurately identified high-grade prostate cancer through urine testing.
4.
Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds
5.
Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US
1.
The Lung Cancer Shift: From Reactive Treatment to Proactive Precision Medicine
2.
Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds
3.
Targeted Therapies for Breast Cancer: What’s New?
4.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
5.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
4.
Efficient Management of First line ALK-rearranged NSCLC - Part III
5.
Thromboprophylaxis In Medical Settings
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge